A Study to Evaluate 68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
To evaluate the diagnostic efficacy of 68Ga FAPI PET/CT in myelofibrosis and to identify fibrosis grades. To evaluate the diagnostic efficacy of 68Ga FAPIPET/CT imaging in patients with myelofibrosis, compared with conventional CT.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Age ≥18 years old;
• Cohort 1: Patients with suspected or confirmed myelofibrosis; Cohort 2: Patients with primary/secondary myelofibrosis who were not treated with ruxolitinib.
• The expected survival time is over 3 months
• Voluntarily sign informed consent.
• Willing and able to follow the research protocol;
• The subject must be able to lie on the scanning bed for 20 minutes;
Locations
Other Locations
China
Bing Xu
RECRUITING
Xiamen
Contact Information
Primary
Bing Xu
xubingzhangjian@126.com
+8618750918842
Backup
Long Liu
kucangyaoren@126.com
+86 151 6000 7832
Time Frame
Start Date: 2023-11-22
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 90
Treatments
suspected or confirmed myelofibrosis
Patients with suspected or confirmed myelofibrosis;
primary/secondary myelofibrosis
Patients with primary/secondary myelofibrosis who were not treated with ruxolitinib.
Related Therapeutic Areas
Sponsors
Leads: The First Affiliated Hospital of Xiamen University